| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.56B | 23.83B | 26.29B | 22.41B | 17.33B | 15.65B |
| Gross Profit | 12.01B | 11.78B | 11.73B | 10.01B | 8.37B | 7.25B |
| EBITDA | 6.18B | 6.31B | 5.88B | 4.43B | 3.45B | 2.95B |
| Net Income | 4.26B | 3.97B | 4.39B | 3.23B | 2.20B | 1.66B |
Balance Sheet | ||||||
| Total Assets | 17.51B | 17.07B | 19.86B | 18.41B | 14.58B | 14.66B |
| Cash, Cash Equivalents and Short-Term Investments | 5.51B | 5.44B | 10.74B | 10.91B | 9.27B | 9.64B |
| Total Debt | 14.83M | 10.50M | 21.91M | 29.68M | 10.60M | 15.72M |
| Total Liabilities | 3.67B | 2.81B | 5.58B | 5.22B | 3.71B | 4.35B |
| Stockholders Equity | 13.83B | 14.26B | 14.27B | 13.19B | 10.88B | 10.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.92B | 5.22B | 4.97B | 1.95B | 3.33B |
| Operating Cash Flow | 0.00 | 3.30B | 5.58B | 5.00B | 2.02B | 3.46B |
| Investing Cash Flow | 0.00 | -707.41M | -1.54B | -1.04B | -4.68M | -546.25M |
| Financing Cash Flow | 0.00 | -4.40B | -4.07B | -2.02B | -2.70B | 474.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥110.58B | 13.36 | ― | 4.17% | 1.55% | 1.28% | |
72 Outperform | ¥4.97B | 7.78 | ― | 4.27% | -15.23% | -48.60% | |
71 Outperform | ¥49.17B | 13.22 | ― | 2.56% | -9.37% | -8.21% | |
64 Neutral | ¥9.11B | 3.57 | ― | 3.65% | 12.20% | 78.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥2.14B | -30.79 | ― | ― | 6.81% | -42.68% | |
41 Neutral | ¥6.62B | -20.30 | ― | ― | 51.30% | -26.07% |